Latebreakers: Revision made of Actos label

Article

A request from the FDA has led to a revision of the prescribing information for pioglitazone (Actos, Takeda Pharmaceuticals).

Related Videos
fake news misinformation | Image Credit: Bits and Splits - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.